Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DarioHealth Corp.DRIO · Entity 7024 | Chief Financial Officer | September 24, 2026 | September 28, 2026 |
| Pluri Inc.PLUR · Entity 7728 | Chief Financial Officer | September 18, 2024 | September 20, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DarioHealth Corp.
Report date September 24, 2026 · Filed September 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 125,000 |
Reported balance
After 2026-09-24 transaction · row 1
1 source rowRow 1 · 2026-09-24 · Grant · Acquired 95,000 · Balance 125,000 F1: The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period.
Pluri Inc.
Report date September 18, 2024 · Filed September 20, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 67,503 |
Reported balance
After 2024-09-18 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-09-18 · Grant · Acquired 8,413 · Balance 67,503 F1: The number of shares beneficially owned reflects the 1-for-8 reverse stock split effected on April 1, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The number of shares beneficially owned reflects the 1-for-8 reverse stock split effected on April 1, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 24, 2026 Filed Sep 28, 2026 20:06 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 95,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-111348 · tm2626098-6_4seq1.xml · nonDerivative · entry 1 Franco-Yehuda Chen · CIK 0001770681 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 F1 · date: The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period. Read SEC document |
| September 11, 2025 Filed Sep 15, 2025 20:07 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-090004 · tm2526001-6_4seq1.xml · nonDerivative · entry 1 Franco-Yehuda Chen · CIK 0001770681 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 F1 · date: The restricted share award shall vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period. F2 · balance_after: The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025. Read SEC document |
| May 15, 2025 Filed May 15, 2025 20:02 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-049388 · tm2515033-2_4seq1.xml · nonDerivative · entry 1 Franco-Yehuda Chen · CIK 0001770681 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 F1 · shares: The restricted shares vest over three years, with one third of such shares vesting on April 27, 2026, and the remaining shares vesting in equal quarterly amounts, subject to the Reporting Person's continued services to the Issuer on the applicable vesting date The vesting period shall immediately end, and all shares shall immediately vest, in the event of a change in control of the Registrant (as defined in the Registrant's 2020 Equity incentive Plan, as amended). Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 20:00 UTC | Pluri Inc. PLUR · Entity 7728 | GrantCommon Stock | 8,413 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-080648 · ownership.xml · nonDerivative · entry 1 Franco-Yehuda Chen · CIK 0001770681 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,503 F1 · balance_after: The number of shares beneficially owned reflects the 1-for-8 reverse stock split effected on April 1, 2024. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 21:01 UTC | Pluri Inc. PLUR · Entity 7728 | GrantCommon Stock | 355,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-006455 · ownership.xml · nonDerivative · entry 1 Franco-Yehuda Chen · CIK 0001770681 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 472,716 F1 · date: The RSUs vest over three years as follows: 50% of RSUs will vest on a quarterly basis during the first anniversary of the date of grant, 25% will vest on a quarterly basis during the second anniversary of the date of grant and the remaining 25% will vest on a quarterly basis during the third anniversary of the date of grant. Read SEC document |
| September 10, 2020 Filed Sep 10, 2020 20:50 UTC | Pluri Inc. PSTI · Entity 7728 | GrantRestricted Stock Units | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-026074 · ownership.xml · nonDerivative · entry 1 Franco-Yehuda Chen · CIK 0001770681 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,716 F1 · security: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · date: The shares vest over four years as follows: 12.5% shall vest on the 6 month anniversary of the date of grant and the remaining shares vest in 14 equal installments every 3 months thereafter. F3 · balance_after: Such number of shares of common stock have been adjusted to reflect the reverse stock split that occurred on July 25, 2019. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 20:52 UTC | Pluri Inc. PSTI · Entity 7728 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-19-000983 · zk1922865.xml · nonDerivative · entry 2 Franco-Yehuda Chen · CIK 0001770681 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,158 F2 · date: The shares vest as follows: 12.5% on the 27 month anniversary of the date of grant and the remaining shares vest in 7 equal installments every 3 months thereafter. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 20:52 UTC | Pluri Inc. PSTI · Entity 7728 | GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-19-000983 · zk1922865.xml · nonDerivative · entry 1 Franco-Yehuda Chen · CIK 0001770681 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,158 F1 · date: The shares vest as follows: 25% shall vest on the 6 month anniversary of the date of grant and the remaining shares vest in 6 equal installments every 3 months thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.